Skip to Main Content
Contribute Try STAT+ Today

LAS VEGAS — After a string of costly business failures in health care, IBM CEO Ginni Rometty on Tuesday insisted the company was not retreating from championing the potential of its Watson artificial intelligence capabilities to shake up the medical industry.

“Watson Health is a very important part” of IBM’s business, Rometty told STAT in her first interview on the company’s health division since its manager left in October, after months of uneven financial performance.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.